simvastatin has been researched along with Dilatation, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, LX; Dang, SY; Gao, W; He, CR; Sheng, FQ; Wang, CQ; Wang, W; Xu, R; Zeng, QT | 1 |
| Akbulut, M; Balin, M; Baydas, A; Kayancicek, H; Korkmaz, H; Ozbay, Y | 1 |
2 other study(ies) available for simvastatin and Dilatation, Pathologic
| Article | Year |
|---|---|
In rats with myocardial infarction, interference by simvastatin with the TLR4 signal pathway attenuates ventricular remodelling.
Topics: Animals; Anticholesteremic Agents; Dilatation, Pathologic; Endothelium, Vascular; HSP70 Heat-Shock Proteins; Interleukin-6; Male; Myocardial Infarction; Rats; Simvastatin; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2009 |
The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Dilatation, Pathologic; Female; Humans; Immunoassay; Male; Middle Aged; Prognosis; Simvastatin; Treatment Outcome | 2007 |